ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1391

Differential Expression of Interferon Gamma in Exudate from Hidradenitis Suppurativa Lesions Compared to Chronic Wounds

Anirban Banerjee1, Victoria K. Shanmugam1,2, Sean McNish1 and Kara Couch1, 1Division of Rheumatology, The George Washington University, Washington, DC, 2Director, Division of Rheumatology, The George Washington University, Washington, DC

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cytokines, Interferons and skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster Session II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Hidradenitis suppurativa (HS) is a chronic recurrent inflammatory disease which affects 1% to 4% of young adults. The purpose of the current study was to investigate inflammatory cytokines and growth factors in the effluent from HS lesions compared to effluent from chronic wound specimens. In differentiating the inflammatory profile of HS lesions compared to chronic wounds we hope to identify potential local drivers of inflammation unique to HS over and above inflammatory responses seen in patients with chronic wounds.

Methods:

Wound fluid specimens from 8 patients with HS and 8 age-matched patients with chronic wounds were selected for analysis. Baseline demographics were obtained from the Wound Etiology and Healing (WE-HEAL) database. The Hidradenitis Suppurativa Score a validated HS disease activity score utilized in clinical trials was used to determine extent of HS activity at the time of specimen collection. The Meso Scale Discovery V-Plex cytokine panel 1 and the V-plex proinflammatory panel 1 were used to analyze proinflammatory cytokines in the fluid specimens.

Results:

There was no significant difference in race, sex, presence of diabetes, and cigarette smoking exposures in the HS compared to chronic wound cohorts. Mean HSS in the HS cohort was 68.88 (SD ±41.45) confirming moderately active disease. Interferon-gamma (IFN-γ) was significantly elevated in the HS wound fluid compared to chronic wound samples (Table 1, 1418 ± 1501 pg/ml compared to 102.5 ± 138 pg/ml, p 0.027). HS effluent also had significantly higher levels of TNF-β than chronic wound fluid (Table 1, 9.24 ± 7.22 pg/ml compared to 1.65 ± 2.14 pg/ml, p 0.03). There was no significant difference in any other proinflammatory cytokines including TNF-α, IL-1β, IL-12p70, IL-1α, IL-17A, IL-6, IL-16 and IL12/IL23p40. The anti-inflammatory cytokines IL-10, Il-4, and IL-13, the traditional proliferation cytokines, IL-2, IL-15, Il-7 and IL-5, and the growth factors GM-CSF and VEGF were not significantly different between HS effluent and chronic wound fluid.

Conclusion:

Local molecular drivers of HS are poorly understood. In this study we were able to show that when compared with effluent from chronic wounds HS effluent contains higher levels of the cytokines IFN-γ and TNF-β suggesting that IFN-γ and TNF-β may play a crucial role in driving and perpetuating the exuberant inflammation in HS.

 

WOUND FLUID

HIDRADENITIS

(pg/mL)

N=8

Mean ±SD

CHRONIC WOUND

(pg/mL)

N=8

Mean ±SD

P value

 

AGE

41.61 ± 13.81

45.32 ± 10.43

0.55

NS

PRO-INFLAMMATORY

INF-γ

1418 ± 1501

102.5 ± 138

0.027

*

IL-12p70

9.412 ± 7.59

15.02 ± 27.28

0.609

NS

IL-1β

862.5 ± 1076

1503 ±  3500

0.69

NS

IL-1α

1126 ± 1746

2549 ± 5565

0.5291

NS

IL-17A

1006 ± 1652

32.7 ± 37.36

0.12

NS

IL-6

2377 ± 1604

5451 ± 8180

0.32

NS

TNF-α

83.26 ± 69.07

65.74 ± 105.4

0.70

NS

TNF-β

9.24 ± 7.22

1.65 ± 2.14

0.03

*

IL-16

15277 ± 18785

15586 ± 25553

0.97

NS

IL12/IL23p40

488.3 ± 570.8

97.86 ± 67.06

0.07

NS

ANTI-INFLAMMATORY

IL-10

19.85 ± 18.74

34.74  ± 69.58

0.57

NS

IL-4

6.56 ± 4.15

9.77 ± 13.98

0.54

NS

IL-13

70.98 ± 48.16

55.61 ± 56.10

0.56

NS

PROLIFERATION

IL-2

18.97 ± 18.66

13.16 ± 22.15

0.60

NS

IL-15

24.5 ± 37.29

5.61 ± 4.75

0.18

NS

IL-7

22.29 ± 20.49

10.45 ± 6.28

0.14

NS

IL-5

30.15 ± 33.63

9.314  ± 18.01

0.17

NS

GROWTH FACTOR

GM-CSF

78.45 ± 62.6

82.13 ± 208.8

0.96

NS

VEGF

632.1 ± 757.4

1544 ± 1765

0.23

NS

Table 1: Comparison of cytokines profiles in HS and chronic wounds


Disclosure: A. Banerjee, None; V. K. Shanmugam, None; S. McNish, None; K. Couch, None.

To cite this abstract in AMA style:

Banerjee A, Shanmugam VK, McNish S, Couch K. Differential Expression of Interferon Gamma in Exudate from Hidradenitis Suppurativa Lesions Compared to Chronic Wounds [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/differential-expression-of-interferon-gamma-in-exudate-from-hidradenitis-suppurativa-lesions-compared-to-chronic-wounds/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-expression-of-interferon-gamma-in-exudate-from-hidradenitis-suppurativa-lesions-compared-to-chronic-wounds/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology